146
Views
26
CrossRef citations to date
0
Altmetric
Review

Current management and novel insights in acute pancreatitis

, &
Pages 435-444 | Published online: 10 Jan 2014

References

  • Kozak LJ, Owings MF, Hall MJ. 2005 national hospital discharge survey: annual summary with detailed diagnosis and procedure data. Vital Health Stat.13(158), 1–199 (2002).
  • Isenmann R, Beger HG. Natural history of acute pancreatitis and the role of infection. Baillieres Best Pract. Res. Clin. Gastroenterol.13(2), 291–301 (1999).
  • Banks PA, Freeman ML. Practice guidelines in acute pancreatitis. Am. J. Gastroenterol.101(10), 2379–2400 (2006).
  • Whitcomb DC. Clinical practice. Acute pancreatitis. N. Engl. J. Med.354(20), 2142–2150 (2006).
  • Gumaste VV, Roditis N, Mehta D, Dave PB. Serum lipase levels in nonpancreatic abdominal pain versus acute pancreatitis. Am. J. Gastroenterol.88(12), 2051–2055 (1993).
  • Gwozdz GP, Steinberg WM, Werner M, Henry JP, Pauley C. Comparative evaluation of the diagnosis of acute pancreatitis based on serum and urine enzyme assays. Clin. Chim. Acta187(3), 243–254 (1990).
  • Balthazar EJ, Freeny PC, vanSonnenberg E. Imaging and intervention in acute pancreatitis. Radiology193(2), 297–306 (1994).
  • Balthazar EJ, Fisher LA. Hemorrhagic complications of pancreatitis: radiologic evaluation with emphasis on CT imaging. Pancreatology1(4), 306–313 (2001).
  • Balthazar EJ. Acute pancreatitis: assessment of severity with clinical and CT evaluation. Radiology223(3), 603–613 (2002).
  • Muddana V, Whitcomb DC, Khalid A, Slivka A, Papachristou GI. Elevated serum creatinine as a marker of pancreatic necrosis in acute pancreatitis. Am. J. Gastroenterol.104(1), 164–170 (2009).
  • Lee SP, Nicholls JF, Park HZ. Biliary sludge as a cause of acute pancreatitis. N. Engl. J. Med.326(9), 589–593 (1992).
  • Badalov N, Baradarian R, Iswara K, Li J, Steinberg W, Tenner S. Drug-induced acute pancreatitis: an evidence-based review. Clin. Gastroenterol. Hepatol.5(6), 648–661 (2007).
  • Bradley EL 3rd. A clinically based classification system for acute pancreatitis. Summary of the International Symposium on Acute Pancreatitis, Atlanta, GA, September 11 through 13, 1992. Arch. Surg.128(5), 586–590 (1993).
  • Vege SS, Gardner TB, Chari ST et al. Low mortality and high morbidity in severe acute pancreatitis without organ failure: a case for revising the Atlanta classification to include ‘moderately severe acute pancreatitis’. Am. J. Gastroenterol.104(3), 710–715 (2009).
  • Gardner TB, Vege SS, Chari ST et al. The effect of age on hospital outcomes in severe acute pancreatitis. Pancreatology8(3), 265–270 (2008).
  • Martinez J, Sanchez-Paya J, Palazon JM, Suazo-Barahona J, Robles-Diaz G, Perez-Mateo M. Is obesity a risk factor in acute pancreatitis? A meta-analysis. Pancreatology4(1), 42–48 (2004).
  • Papachristou GI, Papachristou DJ, Avula H, Slivka A, Whitcomb DC. Obesity increases the severity of acute pancreatitis: performance of APACHE-O score and correlation with the inflammatory response. Pancreatology6(4), 279–285 (2006).
  • Wang YL, Hu R, Lugea A et al. Ethanol feeding alters death signaling in the pancreas. Pancreas32, 351–359 (2006).
  • Papachristou GI, Papachristou DJ, Morinville VD, Slivka A, Whitcomb DC. Chronic alcohol consumption is a major risk factor for pancreatic necrosis in acute pancreatitis. Am. J. Gastroenterol.101(11), 2605–2610 (2006).
  • Lindkvist B, Appelros S, Manjer J, Berglund G, Borgstrom A. A prospective cohort study of smoking in acute pancreatitis. Pancreatology8, 63–70 (2008).
  • Papachristou GI, Sass DA, Avula H et al. Is the monocyte chemotactic protein-1 -2518G allele a risk factor for severe acute pancreatitis? Clin. Gastroenterol. Hepatol.3(5), 475–481 (2005).
  • Rahman SH, Salter G, Holmfield JH, Larvin M, McMahon MJ. Soluble CD14 receptor expression and monocyte heterogeneity but not the C-260T CD14 genotype are associated with severe acute pancreatitis. Crit. Care Med.32(12), 2457–2463 (2004).
  • Balog A, Gyulai Z, Boros LG et al. Polymorphism of the TNF-α, HSP70-2, and CD14 genes increases susceptibility to severe acute pancreatitis. Pancreas30(2), E46–E50 (2005).
  • Ranson JH, Rifkind KM, Roses DF, Fink SD, Eng K, Spencer FC. Prognostic signs and the role of operative management in acute pancreatitis. Surg. Gynecol. Obstet.139(1), 69–81 (1974).
  • Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit. Care Med.13(10), 818–829 (1985).
  • Balthazar EJ, Robinson DL, Megibow AJ, Ranson JH. Acute pancreatitis: value of CT in establishing prognosis. Radiology174(2), 331–336 (1990).
  • Forsmark CE, Baillie J. AGA Institute technical review on acute pancreatitis. Gastroenterology.132(5), 2022–2044 (2007).
  • Brown A, Orav J, Banks PA. Hemoconcentration is an early marker for organ failure and necrotizing pancreatitis. Pancreas20(4), 67–72 (2000).
  • Tenner S. Initial management of acute pancreatitis: critical issues during the first 72 h. Am. J. Gastroenterol.99(12), 2489–2494 (2004).
  • Helm JF, Venu RP, Geenen JE et al. Effects of morphine on the human sphincter of Oddi. Gut29(10), 1402–1407 (1988).
  • Turina M, Fry DE, Polk HC. Acute hyperglycemia and the innate immune system: clinical, cellular, and molecular aspects. Crit. Care Med.33(7), 1624–1633 (2005).
  • Papachristou GI, Clermont G, Sharma A, Yadav D, Whitcomb DC. Risk and markers of severe acute pancreatitis. Gastroenterol. Clin. North Am.36(2), 277–296 (2007).
  • Kingsnorth AN, Galloway SW, Formela LJ. Randomized, double-blind Phase II trial of lexipafant, a platelet activating factor antagonist, in human acute pancreatitis. Br. J. Surg.82(10), 1414–1420 (1995).
  • Johnson CD, Kingsnorth AN, Imrie CW et al. Double blind, randomised, placebo controlled study of a platelet activating factor antagonist, lexipafant, in the treatment and prevention of organ failure in predicted severe acute pancreatitis. Gut48(1), 62–69 (2001).
  • Van Laethem JL, Marchant A, Delvaux A et al. Interleukin 10 prevents necrosis in murine experimental acute pancreatitis. Gastroenterology108(6), 1917–1922 (1995).
  • Deviere J, Le Moine O, Van Laethem JL et al. Interleukin 10 reduces the incidence of pancreatitis after therapeutic endoscopic retrograde cholangiopancreatography. Gastroenterology120(2), 498–505 (2001).
  • Oruc N, Ozutemiz AO, Yukselen V et al. Infliximab: a new therapeutic agent in acute pancreatitis? Pancreas28(1), E1–E8 (2004).
  • Furuya T, Komatsu M, Takahashi K et al. Plasma exchange for hypertriglyceridemic acute necrotizing pancreatitis: report of two cases. Ther. Apher.6(6), 454–458 (2002).
  • McClave SA, Chang WK, Dhaliwal R, Heyland DK. Nutrition support in acute pancreatitis: a systematic review of the literature. JPEN J. Parenter. Enteral. Nutr.30(2), 143–156 (2006).
  • Shaw JH, Wolfe RR. Glucose, fatty acid, and urea kinetics in patients with severe pancreatitis. The response to substrate infusion and total parenteral nutrition. Ann. Surg.204(6), 665–672 (1986).
  • Jacobson BC, Vander Vliet MB, Hughes MD, Maurer R, McManus K, Banks PA. A prospective, randomized trial of clear liquids versus low-fat solid diet as the initial meal in mild acute pancreatitis. Clin. Gastroenterol. Hepatol.5(8), 946–951 (2007).
  • McClave SA. Nutrition support in acute pancreatitis. Gastroenterol. Clin. North Am.36(1), 65–74 (2007).
  • Kaushik N, Pietraszewski M, Holst JJ, O’Keefe SJ. Enteral feeding without pancreatic stimulation. Pancreas31(4), 353–359 (2005).
  • Vu MK, Verkijk M, Muller ES, Biemond I, Lamers CB, Masclee AA. Medium chain triglycerides activate distal but not proximal gut hormones. Clin. Nutr.18(6), 359–363 (1999).
  • Marik PE, Zaloga GP. Meta-analysis of parenteral nutrition versus enteral nutrition in patients with acute pancreatitis. BMJ328(1407), 7453 (2004).
  • O’Keefe SJ, Broderick T, Turner M, Stevens S, O’Keefe JS. Nutrition in the management of necrotizing pancreatitis. Clin. Gastroenterol. Hepatol.1(4), 315–321 (2003).
  • Lévy P, Heresbach D, Pariente EA et al. Frequency and risk factors of recurrent pain during refeeding in patients with acute pancreatitis: a multivariate multicentre prospective study of 116 patients. Gut40(2), 262–266 (1997).
  • Eatock FC, Chong P, Menezes N et al. A randomized study of early nasogastric versus nasojejunal feeding in severe acute pancreatitis. Am. J. Gastroenterol.100(2), 432–439 (2005).
  • Neoptolemos JP, Carr-Locke DL, London NJ, Bailey IA, James D, Fossard DP. Controlled trial of urgent endoscopic retrograde cholangiopancreatography and endoscopic sphincterotomy versus conservative treatment for acute pancreatitis due to gallstones. Lancet2(8618), 979–983 (1988).
  • Fan ST, Lai EC, Mok FP, Lo CM, Zheng SS, Wong J. Early treatment of acute biliary pancreatitis by endoscopic papillotomy. N. Engl. J. Med.328(4), 228–232 (1993).
  • Fölsch UR, Nitsche R, Lüdtke R, Hilgers RA, Creutzfeldt W. Early ERCP and papillotomy compared with conservative treatment for acute biliary pancreatitis. The german study group on acute biliary pancreatitis. N. Engl. J. Med.336(4), 237–242 (1997).
  • Oría A, Cimmino D, Ocampo C et al. Early endoscopic intervention versus early conservative management in patients with acute gallstone pancreatitis and biliopancreatic obstruction: a randomized clinical trial. Ann. Surg.245(1), 10–17 (2007).
  • Ayub K, Imada R, Slavin J. Endoscopic retrograde cholangiopancreatography in gallstone-associated acute pancreatitis. Cochrane Database Syst. Rev. (4), CD003630 (2004).
  • Baron TH, Harewood GC, Morgan DE, Yates MR. Outcome differences after endoscopic drainage of pancreatic necrosis, acute pancreatic pseudocysts, and chronic pancreatic pseudocysts. Gastrointest. Endosc.56(1), 7–17 (2002).
  • Bassi C, Larvin M, Villatoro E. Antibiotic therapy for prophylaxis against infection of pancreatic necrosis in acute pancreatitis. Cochrane Database Syst. Rev. (4), CD002941 (2003).
  • Isenmann R, Rünzi M, Kron M et al. German antibiotics in severe acute pancreatitis study group. prophylactic antibiotic treatment in patients with predicted severe acute pancreatitis: a placebo-controlled, double-blind trial. Gastroenterology126(4), 997–1004 (2004).
  • Dellinger EP, Tellado JM, Soto NE et al. Early antibiotic treatment for severe acute necrotizing pancreatitis: a randomized, double-blind, placebo-controlled study. Ann. Surg.245(5), 674–683 (2007).
  • Bai Y, Gao J, Zou DW, Li ZS. Prophylactic antibiotics cannot reduce infected pancreatic necrosis and mortality in acute necrotizing pancreatitis: evidence from a meta-analysis of randomized controlled trials. Am. J. Gastroenterol.103(1), 104–110 (2008).
  • Bassi C, Falconi M, Talamini G et al. Controlled clinical trial of pefloxacin versus imipenem in severe acute pancreatitis. Gastroenterology115(6), 1513–1517 (1998).
  • Howard TJ, Temple MB. Prophylactic antibiotics alter the bacteriology of infected necrosis in severe acute pancreatitis. J. Am. Coll. Surg.195(6), 759–767 (2002).
  • Eggimann P, Jamdar S, Siriwardena AK. Pro/con debate: antifungal prophylaxis is important to prevent fungal infection in patients with acute necrotizing pancreatitis receiving broad-spectrum antibiotics. Crit. Care10(5), 229 (2006).
  • Hughes SJ, Papachristou GI, Federle MP, Lee KK. Necrotizing pancreatitis. Gastroenterol. Clin. North Am.36(2), 313–323 (2007).
  • Mier J, León EL, Castillo A, Robledo F, Blanco R. Early versus late necrosectomy in severe necrotizing pancreatitis. Am. J. Surg.73(2), 71–75 (1997).
  • Papachristou GI, Takahashi N, Chahal P, Sarr MG, Baron TH. Peroral endoscopic drainage/debridement of walled-off pancreatic necrosis. Ann. Surg.245(6), 943–951 (2007).
  • Aoun E, Papachristou GI, Whitcomb D, Ahmad I, Slivka A. Acute deterioration of a woman following acute pancreatitis with pseudocysts. Nat. Clin. Pract. Gastroenterol. Hepatol.2(11), 545–549 (2005).
  • Heider TR, Azeem S, Galanko JA, Behrns KE. The natural history of pancreatitis-induced splenic vein thrombosis. Ann. Surg.239(6), 876–882 (2004).

Website

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.